The MMP12 82A/G polymorphism has been associated with increased susceptibility to ovarian cancer [176,177], and MMP13 in ascitic fluids of ovarian cancer patients has been identified as a potential marker for disease risk and survival outcomes [178]. This evidence concerns the gene MMP13 and ovarian cancer.